4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000176
Chief Medical Officer sold 3,743 shares at an average $13.81 ($51,684)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2025-08-12 | Sale 10b5-1 | −2,937 | $13.58 | $39,884 | 217,391 | D |
| Ho Carole Chief Medical Officer | 2025-08-13 | Sale 10b5-1 | −806 | $14.64 | $11,800 | 216,585 | D |
| Open-market sales · 3,743 sh · avg $13.81 · $51,684 | |||||||
Loading xslF345X05/wk-form4_1755217980.xml…